Jimmy Shan

Stock Analyst at RBC Capital

(3.25)

# 978

Out of 4,843 analysts

13

Total ratings

64.29%

Success rate

11.42%

Average return

Main Sectors:

Healthcare Real Estate

Top Industries:

Biotechnology Real Estate Services

Stocks Rated by Jimmy Shan

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TRML Tourmaline Bio	Initiates: Outperform	$58	$16.68	+247.72%	1	Feb 24, 2025
	CIGI Colliers International Group	Maintains: Outperform	$170 → $175	$120.48	+45.25%	12	Feb 7, 2025

Tourmaline Bio

Feb 24, 2025

Initiates: Outperform

Price Target: $58

Current: $16.68

Upside: +247.72%

Colliers International Group

Feb 7, 2025

Maintains: Outperform

Price Target: $170 → $175

Current: $120.48

Upside: +45.25%